Dr. Ko joined Stanford Medicine in 2012 and serves as Director and Chief of Medical Dermatology for Stanford Health Care (SHC) while also spearheading the dermatology department's efforts around network development, digital health, quality/safety/performance improvement, and value-based care. He is active in a number of leadership roles within the organization including co-chairing the Clinic Advisory Council, a forum of medical and executive leaders of Stanford Health Care?s Ambulatory clinics, and as a Service Medical Director.
His passion for melanoma, early cancer detection, and improving care delivery drives his efforts and research around leveraging advances in machine learning and artifical intelligence to increase the breadth of populations that can be reached. He developed and runs a digital care delivery program at SHC, providing virtual visits for patients and remote consultations for referring clinicians. He conducts research on and engages in collaborations around interventions that layer advances in machine learning on digital health capabilities to enhance access, quality and value of dermatologic care. He chairs the American Academy of Dermatology's Task Force Committee on Augmented Intelligence.
Dr. Ko has also been driven to find new treatments for alopecia areata, an immune-mediated condition that can progress to total hair loss through various clinical trials and translational research efforts. He sits on the clinical research advisory board of the National Alopecia Areata Foundation and is founder and co-director of the Skin Innovation and Interventional Research Group (SIIRG) which conducts clinical and translational research on skin disease.
He graduated magna cum laude from Harvard University and worked in investment banking; mergers and acquisitions at JP Morgan before going on to earn a combined medical and business degree at Tufts University. During medical school, he was a member of the Alpha Omega Alpha honor society. Dr. Ko then performed his residency at the Harvard Dermatology Residency Training Program where he served as chief resident.
- Skin Cancer
- Alopecia Areata
- Screening for melanoma in high risk patients (family history, red hair, many moles)
- Laser Therapy of Medical Skin Conditions
- Artificial Intelligence and Machine Learning
Medical Director and Chief, Medical Dermatology, Stanford Health Care (2012 - Present)
Co-Chair, Clinic Advisory Council, Stanford Health Care (2018 - Present)
Director of Network Development and Digital Health, Stanford Department of Dermatology (2012 - Present)
Physician Leader, Safety, Quality and Performance Improvement, Stanford Department of Dermatology (2017 - Present)
Director of Value Based Care, Stanford Department of Dermatology (2020 - Present)
Medical Director, Service Excellence, Stanford Health Care (2018 - Present)
Member, Ambulatory Value Optimization Committee, Stanford Health Care (2018 - Present)
Member, Access Management Guidance Team, Stanford Health Care (2018 - Present)
Member, Clinic Advisory Council, Stanford Hospital and Clinics (2015 - Present)
Physician Lead and Co-Chair, Clinic Performance Team 4, Stanford Hospital and Clinics (2015 - 2018)
Boards, Advisory Committees, Professional Organizations
Chair, American Academy of Dermatology Task Force on Augmented Intelligence (2019 - Present)
Research Advisory Council, National Alopecia Areata Foundation (2016 - Present)
Board Certification: American Board of Dermatology, Dermatology (2012)
Chief Resident, Harvard Combined Dermatology Residency Training Program (2012)
Residency: Massachusetts General Hospital (2012) MA
BA, Harvard University, Magna Cum Laude (2002)
MD, MBA, Tufts University School of Medicine, Alpha Omega Alpha (2008)